propargyloxyphenyl) hexanamide (MS-PPOH) reduced the local dilation caused by ATP. The conducted dilation was attenuated by MS-PPOH and endothelial impairment, but not N -monomethyl-L -arginine or indomethacin. Conclusion: ATP-induced conducted dilation is preceded by membrane hyperpolarization. Local ATP induces initial local constriction via smooth-muscle P 2X1 and subsequent dilation via endothelial P 2Y receptors. Nitric oxide, cytochrome P450 metabolites, and intermediate and large conductance K Ca channels mediate dilation caused by ATP. ATP-induced conducted dilation is dependent upon both the endothelium and cytochrome P450 metabolites.
leases adenosine triphosphate (ATP), a potent vasoactive agonist in the cerebral circulation [3] [4] [5] [6] . Such ATP, as well as ATP released from other cerebral sources, including perivascular nerves, parenchymal tissue, red blood cells and platelets [see 4 ] could cause local vasomotor responses. Since communication of this local agonist-induced vasoactivity to the proximal supply vessels is required to appropriately adjust local blood flow, the local response must initiate a response which is spread along the vessel; that is, the response must be conducted [7] .
In rat penetrating arterioles, locally applied ATP elicits a biphasic response consisting of an initial transient constriction followed by a dilation which is subsequently conducted along the vessel wall [8] [9] [10] . In hamster retractor muscle, extraluminal microapplied ATP caused conducted arteriolar vasoconstriction, while intraluminal ATP caused conducted vasodilation [11] . In hamster cheek pouch arterioles, Duza and Sarelius [12] observed that microapplied ATP caused a local vasoconstriction followed by a conducted vasodilation, a response similar to that observed in cerebral vessels. They determined that the local transient constriction was mediated by P 2x receptors with the subsequent dilation via P 1 receptors with their agonist, the ATP hydrolysis product adenosine [12] . In rat penetrating arterioles, we found that extraluminal ATP stimulates smooth muscle P 2X1 and endothelial P 2Y1 and P 2Y2 receptors [13] . The contribution of P 2 receptors initiating conducted vasomotor responses in penetrating arterioles has not been described.
Inhibition of nitric oxide synthase (NOS) resulted in diminished conducted dilation to intraluminal ATP and enhanced conducted constriction in hamster retractor muscle arterioles, indicating a possible contribution of NO to the conducted vasomotor response in these arterioles [11] . Although the contribution of endothelium-derived hyperpolarizing factor (EDHF) to ATP-induced conduction has not been studied, Hoepfl [14] did report that in hamster cremaster arterioles, the response to locally applied acetylcholine was mediated via EDHF and not by NO. In rat penetrating arterioles, P 2Y receptor stimulation releases NO and possibly EDHF, but not prostanoids [13] . The contribution of NO or EDHF to the conducted response has not been studied in penetrating arterioles.
The underlying mechanism of conducted vasomotor responses is the spread of a local membrane potential change along the vessel via electromechanical coupling. Dora et al. [15] found that in hamster cheek pouch arterioles, local acetylcholine caused a hyperpolarization followed by a dilation, and a subsequent conducted hyperpolarization preceded a conducted dilation. A role for a similar conducted membrane potential change in the ATP-induced conduction has not been studied.
The goal of this study was to examine if electromechanical coupling underlies the observed conducted vasomotor responses to ATP in rat cerebral penetrating arterioles. Further, we wanted to determine the contribution of NOS, cyclooxygenase and cytochrome P450 inhibition on local ATP-receptor-mediated smooth-muscle and endothelial mechanisms involved in conducted vasomotor responses to topical microapplication of ATP in cerebral penetrating arterioles in vitro. In additional experiments, we also examined the possible contribution of K Ca inhibition on the response to extraluminal ATP stimulation, since cytochrome P450-produced epoxyeicosatrienoic acids (EETs) induce vasodilation via stimulation of calcium-activated potassium channels (K Ca ) [16] . We also examined the possible contribution of ectoATPases to extraluminal ATP-induced vasomotor responses.
Materials and Methods

Isolation and Cannulation of Penetrating Arterioles
All procedures were approved by the Washington University Advisory Committee for Animal Resources. Male Sprague-Dawley rats (350-450 g, Harlan, Indianapolis, Ind., USA) were anesthetized with pentobarbital sodium (65 mg/kg intraperitoneally) and sacrificed. The cerebral penetrating arterioles were excised from the middle cerebral artery. Arterioles were transferred to an organ bath (volume 2.5 ml) mounted on the stage of an inverted video microscope (Diaphot, Nikon, Melville, N.Y., USA) and cannulated with glass micropipettes. No intraluminal flow was applied and the transmural pressure was set at 60 mm Hg and continuously monitored. We observed the internal diameter of the vessels using a computerized diameter-tracking system (Diamtrak, Montech Pty. Ltd., Australia).
The arterioles were continuously superfused with a physiological saline solution (37.5 ° C, pH 7.3) of the following composition (in mmol/l): 144 NaCl, 3.0 KCl, 2.5 CaCl 2 , 1.4 MgSO 4 , 2.0 pyruvate, 5.0 glucose, 0.02 ethylenediaminetetraacetic acid, 2.0 3-(Nmorpholino) propanesulfonic acid (MOPS) and 1.21 NaH 2 PO 4 . After equilibration, the vessels developed spontaneous tone and we confirmed their viability by changing the extraluminal pH from 7.3 to 6.8 and from 7.3 to 7.65. Vessels with poor tone ( ! 20% decrease from the maximum diameter) or poor response to pH ( ! 15% change in diameter after pH alteration) were excluded.
Local Microstimulation by ATP
For topical microapplication, ATP (10 mmol/l in distilled water) was backfilled into borosilicate glass micropipettes (World Precision Instruments, Sarasota, Fla., USA) and pulled (using a Model P-87, Sutter Instruments, Novato, Calif., USA) to a tip with 1.5-2.0 m inner diameter. The micropipette was positioned near the arteriolar wall (within 20 m) and ATP was applied by pres-sure ejection (Picospritzer II, General Valve, Fairfield, N.J., USA; 50-450 ms in 100-ms steps at 20 psi using 100% nitrogen gas) resulting in ejected volumes of 50-500 pl onto the abluminal surface of the vessel. These stimulation parameters provided a vasomotor response similar to that observed previously for ATP applied globally into the tissue bath with a 450-ms pulse of ATP equivalent to a global concentration of 100 mol/l ATP [8, 9] . Initially, responses were observed at the site of stimulation (local). The micropipette was then positioned at the opposite end (remote site) of the vessel and the same stimulation was used, enabling observation of conducted responses. The ejected agonist did not spread further than 70 m from the tip at the highest pulse duration, which was consistent with previous observations. Ejections of the control solution had no impact on vessel diameter [8] .
Measurement of Membrane Potential
Membrane potential measurements of vascular smooth muscle were obtained as described earlier [17] . Intracellular electrodes were backfilled with 4 mol/l of potassium acetate and attached to a direct current amplifier (WPI, input impedance of 300 M ⍀ ) with an Ag/AgCl reference electrode. The amplifier output and vessel diameter were recorded simultaneously. Smooth-muscle cells were identified according to their location (they were the cells next to the clearly visible endothelium). To facilitate electrode penetration we used a piezo stepper (Model 5172, Eppendorf, Hamburg, Germany) and penetration was considered successful when we observed a sudden change of membrane potential of at least -25 mV, with removal of the electrode inducing a return of the membrane potential to baseline.
Pharmacological Analysis of Vasomotor Responses to Local ATP Stimulation
The vessel was stimulated locally and remotely in the presence or absence of globally applied inhibitors or after endothelial impairment. All drugs were obtained from Sigma Chemicals (St. Louis, Mo., USA). We used the following inhibitors to analyze the ATP-induced local and conducted responses: 1 mol/l ␣ , ␤ -methylene-ATP ( ␣ , ␤ -MetATP, a P 2X1 receptor antagonist) and 3 mol/l pyridoxal phosphate-6-azophenyl-2 ,4 -disulfonic acid (PPADS, a P 2X1 antagonist at this concentration) [4, 18] ; 100 mol/l PPADS (a P 2X1 and P 2Y1 receptor antagonist at this concentration) [4, 18] ; 10 mol/l N -monomethyl-L -arginine ( L -NMMA, a NOS inhibitor), 10 mol/l indomethacin (cyclooxygenase inhibitor), 1 mol/l N-methylsulfonyl-6-(2-propargyloxyphenyl) hexanamide (MS-PPOH, inhibitor to specifically inhibit the production of EETs) [19] . Air emboli applied at 60 mm Hg intraluminal pressure were used to functionally impair the endothelium without smooth-muscle damage [4] .
Calcium-Sensitive Potassium Channels and Extraluminally
Applied ATP Calcium-sensitive potassium channels are activated by EETs [16] , which may be released in response to ATP. To examine the contribution of K Ca , we observed vasomotor responses to extraluminally applied ATP in the absence or presence of the following potassium channel inhibitors: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34, 0.1 mol/l) applied intraluminally to inhibit endothelial intermediate-conductance calcium-activated potassium channels (IK Ca ) [20] . Extraluminally, we applied apamin (0.1 mol/l) to specifically inhibit small-conductance potassium channels (SK Ca ) [21] and iberiotoxin (0.1 mol/l) to specifically inhibit large-conductance potassium channels (BK Ca ) [20] .
Contribution of ATP Hydrolysis to Extraluminally Applied ATP
Since ecto-ATPases can hydrolyze ATP to adenosine which could stimulate P 1 receptors [12] , and since adenosine receptors are present on the smooth-muscle cells of rat penetrating arterioles [22, 23] , we used 1 mol/l suramin to inhibit ecto-ATPases, thus reducing the production of adenosine [24] .
Statistics
In this study, only one vessel was used from each animal. All data are presented as mean 8 SEM, with n representing the number of observations. Statistics were conducted on absolute vessel diameters. Differences were considered significant at p ! 0. 
Results
Diameter and Membrane Potential Response to Local ATP Application
The vessels used for membrane potential measurements had an average length of 1,240 8 230 m, a maximum diameter of 59.3 8 1.3 m and a tone diameter of 44.8 8 1.1 m, with a resting membrane potential of -36.4 8 3.0 mV (n = 6). Microapplication of ATP resulted in a brief local vasoconstriction followed by a vasodilation ( fig. 1 a) . The conducted response was consistently a vasodilation ( fig. 1 b) . This conducted vasodilation was preceded by a membrane hyperpolarization with stimulus-dependent increases in conducted dilation and membrane hyperpolarization, as shown in figure 1 c and d. For 450-ms pulses, the average maximum hyperpolarization was -16 mV (72.5%) resulting in a significant 6.5 m (10%) dilation at the remote site ( fig. 1 c) . The remote site hyperpolarization was initiated 0.6 8 0.1 s after pulse application, preceding vessel dilation, which occurred at 1.7 8 0.1 s (p ! 0.05), with both responses independent of pulse duration (data not shown). Occasionally, we observed a small yet insignificant depolarization with a subsequent small conducted vasoconstriction prior to the conducted hyperpolarization and dilation (data not shown).
Evaluation of the ATP-Induced Vasomotor Responses to Purinoceptor Inhibition
The vessels used for pharmacological evaluation of local and conducted vasomotor mechanisms had a tone diameter of 36.6 8 1.9 m and a length of 1,072 8 47 m (n = 31). Microapplied ATP induced significant local transient constrictions and subsequent dilations. We consistently observed a conducted dilation, which was sometimes preceded by a small vasoconstriction.
Vessels treated with ␣ , ␤ -MetATP had a maximum diameter of 53.8 8 5.8 m and a tone diameter of 35.1 8 5.7 m (n = 5). 1 mol/l ␣ , ␤ -MetATP applied extraluminally transiently constricted the vessels via smooth muscle P 2X1 receptors with the vessels subsequently returning to their basal diameter due to P 2X1 receptor desensitization [4] . After this desensitization, subsequent ATP-induced local and conducted constrictions were significantly attenuated in the presence of ␣ , ␤ -MetATP, while local and conducted dilations were greatly enhanced ( fig. 2 ).
Vessels treated with PPADS had a maximum diameter of 45.9 8 4.0 m with a tone diameter of 35.8 m (n = 7). PPADS (3 and 100 mol/l) had no effect on the control diameter (data not shown). 3 mol/l PPADS (a P 2X1 receptor antagonist at this concentration) significantly blocked local transient constrictions to ATP, similar to the effect of ␣ , ␤ -MetATP ( fig. 3 ) . The ATP-induced local and conducted dilation was potentiated by 3 mol/l PPADS ( fig. 3 ) . Addition of 100 mol/l PPADS (P 2X1 and P 2Y1 receptor antagonists at this concentration) [18] further inhibited the local transient constriction, but had no additional effect on the conducted dilation ( fig. 3 ) .
Since ecto-ATPases on vascular cells can hydrolyze ATP to adenosine, which activates P 1 receptors causing vasodilation [12] , we used suramin, which has been shown to reduce ecto-ATPase activity at micromolar concentra- fig. 2 ) . Inhibiting all P 2 receptors except P 2Y2 with 100 mol/l PPADS further reduces local transient constriction, but has no further effect on local or conducted dilation, indicating that ATP stimulates P 2Y2 receptors to cause dilation. n = 7. * p ! 0.05 (RANOVA) between ATP control and 3 mol/l PPADS; † p ! 0.05 between 3 and 100 mol/l PPADS (RANOVA).
tions [24] . Vessels used to test the effect of suramin had a maximum diameter of 68.3 8 5.6 m and a tone diameter of 48.0 8 3.8 m (n = 8). When we compared vessel dilations to extraluminal 100 mol/l ATP before and after suramin (1 mol/l), we found no difference in either the dilatory or constrictor responses. The higher concentrations of suramin needed to inhibit P 2Y2 receptors [24] induced complete vessel dilation within the incubation period of 20 min and could not be used. Similarly, the ecto-ATPase inhibitor Reactive Blue 2 [24] , which was used on 7 additional vessels, again dilated the vessels at concentrations higher than 1 mol/l (data not shown). 5 ). However, L -NMMA had no effect on the conduction ( fig. 5 ).
Contribution of Endothelial Impairment and Endothelial Factors (NO, Prostanoids, EETs) to Local and Conducted Vasomotor Responses
Cyclooxygenase inhibition with indomethacin (10 mol/l) influenced neither local nor conducted vasomotor responses (maximum vessel diameter = 51.6 8 2.9 m, tone = 30.9 8 4.6 m, n = 4, data not shown). We used the specific cytochrome P450 inhibitor MS-PPOH to inhibit the de novo production of EETs [19] . The vessels used in these studies had a maximum diameter of 67.0 8 0.6 m with a tone diameter of 52.0 8 2.5 m. 1 mol/l MS-PPOH did not affect the basal vessel diameter (54.3 8 3.8 m) but did significantly attenuate both local and conducted dilation, reducing the dilatory response for pulses from 250 to 450 ms (n = 4; fig. 6 ). In preliminary experiments, we found that higher MS-PPOH concentrations used in in vivo studies dilated our vessel preparation. 
Calcium-Activated Potassium Channels and Extraluminally Applied ATP
Since inhibition of cytochrome P450 resulted in reduced local and conducted vasomotor responses, EETs may contribute to ATP-induced dilation by activating calcium-sensitive potassium channels (K Ca ) [25] . To elucidate the contribution of K Ca to the ATP-induced vasomotor responses, we applied ATP extraluminally in the absence or presence of specific K Ca channel inhibitors. Vessels exposed to TRAM-34 (a specific inhibitor of IK Ca channels) had a maximum diameter of 75.2 8 6.2 m with a tone diameter of 53.2 8 7.8 m (n = 4). Intraluminally applied TRAM-34 (10 mol/l) did not affect basal tone diameter (53.3 8 3.4 m), but inhibited dilation to ATP ( fig. 7 ). Extraluminally applied TRAM-34 had no effect (data not shown). Vessels exposed to iberiotoxin (a specific inhibitor of BK Ca channels) had a maximum diameter of 78. 4 
Discussion
The major findings of this study were, first, that topically microapplied ATP consistently initiated conducted dilation, which was preceded by smooth-muscle hyperpolarization at the remote site in a stimulus-dependent manner. Second, endothelial impairment enhanced local but not conducted constriction and attenuated both local and conducted dilation. Third, microapplied ATP stimulated smooth-muscle P 2X1 receptors causing a transient constriction. Inhibition of P 2X1 receptors attenuated local and conducted constriction and enhanced local and conducted dilation. Local vessel dilation was mediated by endothelial P 2Y receptors, resulting in conducted dilation. Fourth, NO contributes to local dilation at low stimulation pulses but does not contribute to conducted dilation. Cytochrome P450 metabolites contribute to local dilation, and inhibition of cytochrome P450 greatly reduces both local and conducted dilation. Cyclooxygenase products are not involved in either local or conducted responses. Fifth, ATP-induced dilation involves activation of IK Ca and BK Ca channels, but not SK Ca channels.
Local ATP-Induced Vasomotor Responses, Conducted Vasodilation and Membrane Potentials
Microapplication of ATP caused a biphasic response locally with an initial transient constriction followed by a dilation. This corresponds to previous observations by us and others [8, 10, 12] , and is similar to the reaction to globally applied ATP [4] . In our preparation, microapplied adenosine triphosphate consistently resulted in conducted vasodilation (e.g. 20% at 450-ms pulses; fig. 2 ), while the conducted constriction was 5% at a distance of 1,200 m. This result indicates that in our preparation, dilation is more prominently conducted than constriction. Ngai et al. [10] observed a 5% conducted dilation that was preceded by a 5% conducted constriction at a distance of 1,000 m. In hamster cheek pouch arterioles, Duza and Sarelius [12] found that only dilation was conducted in response to local ATP. In the present study, we found that at the remote site, conducted vasodilation was preceded by a membrane hyperpolarization similar to that seen with local acetylcholine stimulation in hamster cheek pouch arterioles [15] . Dora et al. [15] also observed that local acetylcholine-induced dilation was preceded by hyperpolarization, indicating that a local membrane potential change is the generator for the observed vasomotor response and that it is this membrane potential change which is conducted, resulting in the change in vessel diameter via electromechanical coupling. We consistently observed smooth-muscle hyperpolarization preceding the vessel dilation, indicating that electromechanical coupling may also be responsible for the vessel diameter change in our preparation. The local membrane potential response to ATP has not yet been measured in penetrat- ing arterioles. We observed that ATP induced an initial small depolarization with a similarly small constriction, indicating that both membrane depolarization and vessel constriction can be conducted. However, these responses were significantly less pronounced compared with the hyperpolarization and subsequent dilation ( fig. 1 ) . The change in membrane hyperpolarization correlated well with vessel dilation. These findings indicate that in rat penetrating arterioles, the dilation at the remote site is conducted electrically along the arteriolar wall and is caused by hyperpolarization similar to other vessel preparations [15] .
ATP-Induced Vasomotor Responses and Purinergic Receptors
Desensitization of P 2X1 receptors with 1 mol/l ␣ , ␤ -MetATP or pretreatment with 3 mol/l PPADS (P 2X1 receptor antagonists at this concentration) diminished the local transient constriction while the subsequent dilation was potentiated. Endothelial denudation enhanced the ATP-induced vasoconstriction. These results indicate that ATP stimulates smooth-muscle P 2X1 receptors causing constriction [13] . Inhibition of smooth-muscle P 2X1 receptors enhanced conducted dilation, indicating that P 2X1 receptor stimulation competes with the dilatory response both locally and during conduction. We did not measure the smooth-muscle membrane potential at the local stimulation site due to strong vessel wall movement. However, we did observe small depolarizations and conducted constrictions at the distal site ( fig. 1 ) , indicating that membrane depolarization may have occurred locally and that this depolarization was conducted. P 2X -receptor-induced depolarization and contraction was previously observed in vas deferens [26] . The mechanism by which P 2X1 stimulation causes depolarization in cerebral arterioles is not known.
Two endothelial P 2 receptors, P 2Y1 and P 2Y2 , are reported to cause dilation [27] . We recently reported that global ATP activated both endothelial P 2Y1 and P 2Y2 receptors. This conclusion was based on the observation that when the receptors were stimulated by receptor-specific agonists [13] , 100 mol/l PPADS inhibited P 2Y1 , but not P 2Y2 receptor stimulation [4] . Inhibition of P 2X1 receptors with 3 mol/l PPADS enhanced local dilation, indicating that endothelial P 2Y receptors are present [4] . However, we found no difference in ATP-induced local dilation in the presence of 100 mol/l PPADS (an inhibitor of all P 2Y receptors except P 2Y2 ) [27] . These findings suggest that microapplied ATP produced dilation primarily via stimulation of the endothelial P 2Y receptor. We also observed no change in conducted vasodilation after the inhibition of P 2Y1 receptors with 100 mol/l PPADS, indicating that local endothelial P 2Y , possibly via P 2Y2 stimulation, is the generator for the conducted vasodilation. Suramin and Reactive Blue 2 inhibit P 2Y2 receptors at concentrations of 20 mol/l and higher [24] . However, concentrations of these inhibitors greater than 1 mol/l dilated our vessel preparation and could not be used. In the hamster cheek pouch, Duza and Sarelius [12] reported that conducted vasomotor responses to locally applied ATP and adenosine depend on endothelial P 1 receptors, with ATP being hydrolyzed to adenosine [24] . Rat penetrating arterioles, which have adenosine receptors present on the smooth muscle but not the endothelium [22, 23] , strongly dilated to locally applied adenosine but did not show conduction [8] . We used a low concentration of suramin to reduce hydrolysis of ATP by ecto-ATPases [24] and found no change in vessel dilation to extraluminally applied ATP. This suggests that in rat penetrating arterioles, ATP hydrolysis with subsequent adenosine receptor stimulation was not causing the observed dilation. Due to the dilatory effect of the higher concentration of suramin (or Reactive Blue 2), we were unable to determine directly if P 2Y2 receptor stimulation is responsible for the observed local ATP response. Future experiments with specific P 2Y1 and P 2Y2 agonists should help to elucidate which receptor is involved in the local and conducted vasomotor responses to ATP [13] .
Our results show that inhibiting the smooth-muscle P 2X1 receptor enhanced the local endothelial P 2Y -receptor-dependent dilation and the conducted dilation. This seems to indicate that the P 2X1 receptor response counteracts the P 2Y -induced hyperpolarization and dilation, since the conducted dilation is also enhanced. Further, only local responses that cause a change in the membrane potential contribute to conducted responses, as indicated by others [15] .
Contribution of NO, Prostanoids and EDHF
Endothelial P 2Y activation releases NO, prostanoids or EDHF, depending on the species and P 2Y receptor type studied [27] . Inhibition of cyclooxygenase had no effect on ATP-induced local or conducted vasomotor responses in our preparation. The finding that prostanoids may not be involved is similar to our previous findings [13] and those of others in the cerebral circulation [28] . Inhibition of NOS decreased dilation only at short pulse durations. This corresponds with our previous study, where NOS inhibition only affected ATP induced dilation at low agonist concentrations [13] , which was similar to response in larger cerebral vessels [28] . We previously found that specific P 2Y1 receptor stimulation releases both NO (at low agonist concentrations) and an EDHF at higher concentration, while P 2Y2 stimulation releases only an EDHF [13] . Inhibition of NOS had no effect on conducted vasomotor responses, indicating that NO does not contribute to the generation of the conducted response or conduction itself, possibly because NO does not affect the arteriolar membrane potential as an EDHF would do. The effect of NOS inhibition on the membrane potential has not been measured in our preparation. Hoepfl et al. [14] observed that in hamster cremaster arterioles, NO is not critical for acetylcholine-induced conducted vasodilation. However, Collins et al. [29] reported that in hamster retractor muscle, inhibition of NOS did eliminate retrograde conducted vasodilation to intravenular ATP.
To test for the contribution of EDHFs, we applied the specific cytochrome P450 inhibitor MS-PPOH, which strongly attenuated both local and conducted ATP-induced dilation, indicating that de novo synthesized EETs may be involved in the dilatory response [30] . These findings are similar to those of Hoepfl et al. [14] , who found that cytochrome P450 inhibition with 17-octadecynoic acid reduced local and conducted vasomotor responses to acetylcholine in hamster cremaster arterioles.
Calcium-Sensitive Potassium Channels and ATP-Induced Vasomotor Responses
EETs can cause dilation through activation of calcium-sensitive potassium channels and subsequent membrane hyperpolarization [16] . Since it is not known if ATP activates calcium-sensitive potassium channels in rat penetrating arterioles, we sought to elucidate the contribution of these channels to vasomotor responses to extraluminally applied ATP. We used specific inhibitors of these channels. We found that BK Ca and IK Ca , but not SK Ca , channels contribute to ATP-induced dilation. Activation of K Ca channels causes hyperpolarization, contributing to the local dilation [31] . These results indicate that EETs generated by cytochrome P450 may contribute to ATP-induced local dilation, possibly by activating potassium channels [16] .
Taken together, these results suggest that microapplied ATP may locally release endothelial NO (at low stimulation pulses) and cytochrome P450 metabolites (P 2Y stimulation) causing dilation. Since EETs produced by cytochrome P450 can activate potassium channels [16] , ATP may, in part, dilate penetrating arterioles by activating IK Ca and BK Ca channels to initiate the conducted response.
Local Stimulation and Extraluminal Antagonists
In the present studies, we employed microapplication to cause a local vasomotor response and we applied inhibitors extraluminally. Thus, after inhibition, the changed vasomotor responses at the local site reflected the contribution of the inhibited mechanisms (e.g. NO or EDHF) on the local vessel response. Since we applied inhibitors globally, it is possible that the inhibitors not only affected the local vasomotor response, but also the conduction along the vessel and/or the remote vasomotor response. Thus, future experiments with focal application of inhibitors (e.g. inhibitor only at the local or the remote site) have to be done to distinguish which mechanisms are involved in the local and/or remote vasomotor responses.
Pathology and Conducted Vasodilation in Cerebral Arterioles
In these studies, damage to the endothelium induced by air embolization resulted in constriction of the penetrating arterioles, which effectively raises microvascular resistance. In addition, we observed that the local constriction was enhanced and local and conducted vasodilation to ATP was attenuated. Air embolization of microvessels damages the endothelial function, but does not remove the endothelial cells [4, 32] . It is therefore possible that the residual endothelial cell layer still provided a conduit to allow conducted responses [4] .
Conducted vasodilation is a prerequisite to allow an increase in microvascular flow in response to local metabolic demand [7] . Thus, impairment of endothelial function and the subsequent reduction in conducted vasodilation in penetrating arterioles may further decrease cerebral microvascular blood flow. The reduction in conducted dilation is similar to the effect of oxyhemoglobin [9] .
Interplay of Local Endothelial and Smooth-Muscle Factors Resulting in Local and Conducted Vasomotor Responses
Our results indicate that ATP locally stimulates smooth-muscle P 2X1 receptors, causing local constriction and some conducted depolarization or constriction ( fig. 1 d, 2 , 3 ). This indicates that P 2X1 -induced constriction may involve a local depolarization. We found that ATP stimulates P 2Y1 and P 2Y2 receptors, where P 2Y1 stimulation appears to liberate NO and a non-NO-and noncyclooxygenase-dependent factor, possibly an EDHF dependent on cytochrome P450 [13] , and P 2Y2 liberates only a non-NO-and non-cyclooxygenase-dependent factor (i.e. EDHF) [13] . As such, both NO and an EDHF may contribute to the local dilation. For a local response to lead to a conducted one, most studies indicate that a local membrane potential change has to occur [15] . However, inhibition of NO did not result in a decreased conducted dilation. Thus, it appears that only the EDHF component contributes to a local membrane potential change leading to conduction, but NO causes local dilation without hyperpolarization. Therefore, while inhibition of NO decreased the local dilation, the EDHF component was unaltered and the conducted response unchanged. Inhibition of either NO or EDHF resulted in a decreased local dilatory response, but not enhanced constriction. It is possible that the presence of the noninhibited dilator (either NO or EDHF) was sufficient to prevent an increased constriction. This is supported by the observation that air embolus-induced endothelial damage caused increased smooth-muscle constriction to ATP. Our data therefore shows an intricate interplay among the various factors invoked by ATP stimulation on both local and conducted responses.
In summary, in rat cerebral arterioles in vitro, microapplication of ATP produces a biphasic response resulting in a transient constriction via smooth-muscle P 2X1 receptors and subsequent dilation, primarily due to endothelial P 2Y receptor activation. Conducted vasomotor responses travel along the vessel with a membrane hyperpolarization that precedes vessel dilation. ATP produces NO and cytochrome P450 metabolites (EETs) which locally dilate the vessel, but NO does not contribute to conduction. Activation of IK Ca and BK Ca , but not SK Ca , channels may contribute to ATP-induced dilation.
